Market access, pricing and reimbursement

Payer market research expertise

The payer environment for innovative therapies is becoming increasingly competitive. Leveraging our team’s industry experience in pharmaceutical market research, market access and commercialization, we work with you to map a clear path towards optimized access and value-based pricing for your portfolio.

We will help you:

  • define the medical, health, economic and societal value proposition of your asset
  • provide a global value dossier and local adaptation in key markets
  • support local access strategies by conducting appropriate studies into burden of disease, cost/benefit and budget impact
  • generate strategic insights by conducting global payer research
  • provide health economic input into clinical trials and registry design
  • support value based pricing

Payer market research expertise

The payer environment for innovative therapies is becoming increasingly competitive. Leveraging our team’s industry experience in pharmaceutical market research, market access and commercialization, we work with you to map a clear path towards optimized access and value-based pricing for your portfolio.

We will help you:

• define the medical, health, economic and societal value proposition of your asset
• provide a global value dossier and local adaptation in key markets
• support local access strategies by conducting appropriate studies into burden of disease, cost/benefit and budget impact
• generate strategic insights by conducting global payer research
• provide health economic input into clinical trials and registry design
• support value based pricing

Case study: payer research in metastatic breast cancer

Challenge

An established US biotech, aware of the importance of incorporating market access factors into clinical trial design, wanted to conduct strategic research for a novel advanced breast cancer therapy about to enter Phase II trials.

Solution

We developed hypotheses from research of the current market for breast cancer therapies, focusing particularly on labels and clinical trial designs for recently launched products.

Based on two scenarios for the product’s performance, our market access consultants conducted a series of interviews with payers and key opinion leaders in the USA, Germany, France, Spain and the UK.

The key objective was to understand the extent to which health economics and outcomes research (HEOR) data would be valued by payers in each scenario and exactly what kinds of HEOR data would be useful, for example, mobility, pain, QoL metrics preferred by payers, caregiver burden and any other patient reported outcomes. We also explored the broader market access environment in advanced breast cancer.

Our findings informed the design of Phase II trials, ensuring that the differentiation elements perceived and valued by payers were adequately captured.

Further case studies regarding market access consulting and the pharmaceutical market research Alacrita performs in payer market research are available here.

Related Case Studies

Stay in touch